This federal contract award, valued at $14,297.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,328,017 units of the drug Eliquis 5 mg tablets, with a completion date of November 5, 2024.
The award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/3/25, 1:27 PM